April 24, 2017

Dan Alford, MD, MPH; Phillip Coffin, MD; Melissa Weimer, DO, MCR

Begin Course  View Presentation Slides

Educational objectives:

  • Describe universal precautions and their role in opioid therapy
  • Review monitoring and documentation strategies for opioid therapy
  • Explain the fundamental principles of urine drug testing and interpretation
  • List the differential diagnosis for aberrant drug related behavior
  • Describe when naloxone co-prescription should be considered

Accreditation:
American Academy of Addiction Psychiatry (AAAP) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation:
American Academy of Addiction Psychiatry (AAAP)  designates this enduring material for a maximum of 1 (one) AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

PA Accreditation:
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 1 Category 1 credits for completing this activity.

Method of participation in the learning process:
In order to receive a maximum of 1 AMA PRA Category 1 Credit™, participants must participate in the entire module, answer post-test questions, pass with a 70% pass rate and complete an evaluation at the end of the activity.